Welcome to LookChem.com Sign In|Join Free
  • or
1,2-Pyrrolidinedicarboxylic acid, 3-(1,1-dimethylethoxy)-, 1-(9H-fluoren-9-ylmethyl) ester, (2S,3R)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

443899-48-7

Post Buying Request

443899-48-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

443899-48-7 Usage

Ester derivative

Pyrrolidinedicarboxylic acid and fluorene

Chiral center

S and R configuration at the second and third positions

Potential applications

Pharmaceutical industry, materials science, chemical industries

Possible uses

Drug development, specialized polymers, and other materials

Further research

Necessary to understand and harness the potential uses of the compound

Check Digit Verification of cas no

The CAS Registry Mumber 443899-48-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,3,8,9 and 9 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 443899-48:
(8*4)+(7*4)+(6*3)+(5*8)+(4*9)+(3*9)+(2*4)+(1*8)=197
197 % 10 = 7
So 443899-48-7 is a valid CAS Registry Number.

443899-48-7Downstream Products

443899-48-7Relevant academic research and scientific papers

Bicyclic peptidomimetic tetrahydrofuro[3,2-b]pyrrol-3-one and hexahydrofuro[3,2-b]pyridine-3-one based scaffolds: Synthesis and cysteinyl proteinase inhibition

Quibell, Martin,Benn, Alex,Flinn, Nick,Monk, Tracy,Ramjee, Manoj,Wang, Yikang,Watts, John

, p. 5689 - 5710 (2007/10/03)

Fmoc protected 5,5 and 6,5-bicyclic ketones 12 and 13 were prepared through the corresponding diazomethylketone intermediates via a lithium chloride/acetic acid promoted carbene insertion reaction. Building blocks 12 and 13 were used in the solid phase synthesis of peptidomimetic inhibitors of a range of CAC1 cysteinyl proteinases. Compound 10, a potent and selective inhibitor of cathepsin K exhibited promising activity in an in vitro cell-based human osteoclast assay of bone resorption. A stereoselective synthesis of (3aS,6aR)-tetrahydrofuro[3,2-b]pyrrol-3-ones and (3aS,7aR)-hexahydrofuro[3,2-b] pyridine-3-ones has been developed through Fmoc protected scaffolds 12 and 13. A key design element within these novel bicyclic scaffolds, in particular the 5,5-fused system, was the inherent stability of the cis-fused geometry in comparison to that of the corresponding trans-fused. Since the bridgehead stereocentre situated α to the ketone was of a fixed and stable configuration, the fact that cis ring fusion is both kinetically and thermodynamically stable with respect to trans ring fusion provides chiral stability to the bridgehead stereocentre that is situated β to the ketone. To exemplify this principle, building blocks 12 and 13 were designed, prepared and utilised in a solid phase combinatorial synthesis of peptidomimetic inhibitors 10, 45a-e, 11 and 46. Both series were chirally stable with 5,5-series 10 and 45a-e exhibiting potent in vitro activity against a range of CAC1 cysteinyl proteinases. Compound 10, a potent and selective inhibitor of cathepsin K, possessed good primary DMPK properties along with promising activity in an in vitro cell-based human osteoclast assay of bone resorption.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 443899-48-7